Expression of MicroRNA machinery proteins in different types of chronic rhinosinusitis

Laryngoscope

Volumn 122, Issue 12, 2012, Pages 2621-2627

  Zhang, Ya Na ^a   Cao, Ping Ping ^a   Zhang, Xin Hao ^a   Lu, Xiang ^a   Liu, Zheng ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

chronic rhinosinusitis; eosinophil; MicroRNA machinery; nasal polyp; plasma cell; protein activator of the interferon induced protein kinase

Indexed keywords

ARGONAUTE 2 PROTEIN; FRAGILE X MENTAL RETARDATION PROTEIN; INTERFERON; MICRORNA; PROTEIN ACTIVATOR OF THE INTERFERON INDUCED PROTEIN KINASE; PROTEIN KINASE; RNA BINDING PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE CONTROL STUDY; CHRONIC RHINOSINUSITIS; CONTROLLED STUDY; EXPERIMENTAL STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NASAL BIOPSY; NOSE POLYP; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ADULT; CHRONIC DISEASE; EOSINOPHILS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICRORNAS; MIDDLE AGED; NASAL MUCOSA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHINITIS; RNA-BINDING PROTEINS; SINUSITIS; YOUNG ADULT;

EID: 84871345152     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.23517     Document Type: Article

References (37)

1. Meltzer EO, Hamilos DL, Hadley JA, et al. Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol 2004; 114: 155-212.
2. Fokkens W, Lund V, Mullol J, European Position Paper on Rhinosinusitis and Nasal Polyps Group. European position paper on rhinosinusitis and nasal polyps 2007. Rhinol Suppl 2007;(20): 1-136.
3. Polzehl D, Moeller P, Riechelmann H, Perner S,. Distinct features of chronic rhinosinusitis with and without nasal polyps. Allergy 2006; 61: 1275-1279.
4. Van Zele T, Claeys S, Gevaert P, et al. Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy 2006; 61: 1280-1289.
5. Cao PP, Li HB, Wang BF, et al. Distinct immunopathologic characteristics of various types of chronic rhinosinusitis in adult Chinese. J Allergy Clin Immunol 2009; 124: 478-484.
6. Bartel DP,. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
7. Ambros V,. The functions of animal microRNAs. Nature 2004; 431: 350-355.
8. Bartel DP,. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136: 215-233.
9. Cowland JB, Hother C, Gronbaek K,. MicroRNAs and cancer. APMIS 2007; 115: 1090-1106.
10. Croce CM, Calin GA,. miRNAs, cancer, and stem cell division. Cell 2005; 122: 6-7.
11. Sonkoly E, Janson P, Majuri ML, et al. MiR-155 is overexpressed in patients with atopic dermatitis and modulates T-cell proliferative responses by targeting cytotoxic T lymphocyte-associated antigen 4. J Allergy Clin Immunol 2010; 126: 581-589.
12. Takaqi T, Naito Y, Mizushima K, et al. Increased expression of microRNA in the inflamed colonic mucosa of patients with active ulcerative colitis. J Gastroenterol Hepatol 2010; 25 (suppl 1): S129-S133.
13. Chen RF, Huang HC, Ou CY, et al. MicroRNA-21 expression in neonatal blood associated with antenatal immunoglobulin E production and development of allergic rhinitis. Clin Exp Allergy 2010; 40: 1482-1490.
14. Lu TX, Munitz A, Rothenberg ME,. MicroRNA-21 is up-regulated in allergic airway inflammation and regulates IL-12p35 expression. J Immunol 2009; 182: 4994-5002.
15. Zhang XH, Zhang YN, Li HB, et al. Overexpression of miR-125b, a novel regulator of innate immunity, in eosinophilic chronic rhinosinusitis with nasal polyps. Am J Respir Care Med 2012; 185: 140-151.
16. Lee Y, Kim M, Han J, et al. MicroRNA genes are transcribed by RNA polymerase II. EMBO J 2004; 23: 4051-4060.
17. Gregory RI, Shiekhattar R,. MicroRNA biogenesis and cancer. Cancer Res 2005; 65: 3509-3512.
18. Schwarz DS, Hutvagner G, Du T, Xu Z, Aronin N, Zamore PD,. Asymmetry in the assembly of the RNAi enzyme complex. Cell 2003; 115: 199-208.
19. Kok KH, Ng MH, Ching YP, Jin DY,. Human TRBP and PACT directly interact with each other and associate with Dicer to facilitate the production of small interfering RNA. J Biol Chem 2007; 282: 17649-17657.
20. Chendrimada TP, Gregory RI, Kumaraswamy E, et al. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature 2005; 436: 740-744.
21. Haase AD, Jaskiewicz L, Zhang H, et al. TRBP, a regulator of cellular PKR and HIV-1 virus expression, interacts with Dicer and functions in RNA silencing. EMBO Rep 2005; 6: 961-967.
22. Lee Y, Hur I, Park SY, Kim YK, Suh MR, Kim VN,. The role of PACT in the RNA silencing pathway. EMBO J 2006; 25: 522-532.
23. Rivas FV, Tolia NH, Song JJ, et al. Purified Argonaute2 and an siRNA form recombinant human RISC. Nat Struct Mol Biol 2005; 12: 340-349.
24. Caudy AA, Myers M, Hannon GJ, Hammond SM,. Fragile X-related protein and VIG associate with the RNA interference machinery. Genes Dev 2002; 16: 2491-2496.
25. Lim LP, Lau NC, Garrett-Engele P, et al. Microarray analysis shows that some microRNAs downregulate large number of target mRNAs. Nature 2005; 433: 769-773.
26. Chiosea S, Jelezcova E, Chandran U, et al. Up-regulation of dicer, a component of the microRNA machinery, in prostate adenocarcinoma. Am J Pathol 2006; 169: 1812-1820.
27. Chiosea S, Jelezcova E, Chandran U, et al. Overexpression of Dicer in precursor lesions of lung adenocarcinoma. Cancer Res 2007; 67: 2345-2350.
28. Chong MM, Rasmussen JP, Rudensky AY, Littman DR,. The RNaseIII enzyme Drosha is critical in T cells for preventing lethal inflammatory disease. J Exp Med 2008; 205: 2005-2017.
29. Liston A, Lu LF, O'Carroll D, Tarakhovsky A, Rudensky AY,. Dicer-dependent microRNA pathway safeguards regulatory T cell function. J Exp Med 2008; 205: 1993-2004.
30. Liu Z, Lu X, Zhang XH, et al. Clara cell 10-kDa protein expression in chronic rhinosinusitis and its cytokine-driven regulation in sinonasal mucosa. Allergy 2009; 64: 149-157.
31. Liu Z, Kim J, Sypek JP, et al. Gene expression profiles in human nasal polyp tissues studied by means of DNA microarray. J Allergy Clin Immunol 2004; 114: 783-790.
32. Liu Z, Lu X, Wang H, You XJ, Gao QX, Cui YH,. Group II subfamily secretory phospholipase A2 enzymes: expression in chronic rhinosinusitis with and without nasal polyps. Allergy 2007; 62: 999-1006.
33. Roh MS, Kwak JY, Kim SJ, et al. Expression of double-stranded RNA-activated protein kinase in small-size peripheral adenocarcinoma of the lung. Pathol Int 2005; 55: 688-693.
34. Van Zele T, Gevaert P, Holtappels G, Van Cauwenberge P, Bachert C,. Local immunoglobulin production in nasal polyposis is modulated by superantigens. Clin Exp Allergy 2007; 37: 1840-1847.
35. Bachert C, Gevaert P, Holtappels G, Johansson SGO, van Cauwenberge P,. Total and specific IgE in nasal polyps is related to local eosinophilic inflammation. J Allergy Clin Immunol 2001; 107: 607-614.
36. Kato A, Peters A, Suh L, et al. Evidence of a role for B cell-activating factor of the TNF family in the pathogenesis of chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol 2008; 121: 1385-1392.
37. Vigorito E, Perks KL, Abreu-Goodger C, et al. MicroRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. Immunity 2007; 27: 847-859.